Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 4-Session class replace punishment for teen drug use?

NCT ID NCT06115746

Knowledge-focused Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 4-session drug education program called iDECIDE for middle and high school students who recently violated their school's substance use policy. About 300 students will be randomly assigned to either take the program right away or wait. Researchers will measure changes in drug knowledge, perceived harm, readiness to quit, and actual substance use over one year. The goal is to see if education can be a better alternative to punitive responses like suspension.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
iDECIDE drug education curriculum (behavioral intervention)
What this could lead to
If successful, this program could offer schools an effective alternative to punishment for student drug infractions, potentially reducing substance use and improving teen knowledge about drugs.
What could go wrong
This is an early-stage behavioral study with 300 participants, so results may not apply broadly. The program may not change actual drug use behavior, and students might not stay engaged over the year-long follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 to 22 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Currently enrolled in middle or high school; 2. Violated school substance use policy within approximately the past month at the time of screening; 3. Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18); 4. Competent and willing to provide written informed assent (if under the age of 18) or written informed consent (if age 18 or older); 5. Able to commit to 9 study visits over approximately one year; 6. Able to safely participate in the protocol and appropriate for outpatient level of care, in the opinion of the investigator; 7. Has access to a reliable internet connection and a device that can run Zoom; 8. Able to read and write comfortably in one of the languages spoken by study staff. Exclusion Criteria: 1. Ever received substance use treatment in an inpatient or specialty care setting; 2. Ever engaged in intravenous (IV) drug use; 3. Current daily use of alcohol, non-medical benzodiazepines, and/or opioid use.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Adolescent Behavior Behavior, Addictive Harm Reduction substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent behavior Harm reduction Substance use

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.